Aging and the dendritic cell system: Implications for cancer

Critical Reviews in Oncology/Hematology

Volumn 64, Issue 2, 2007, Pages 90-105

  Shurin, Michael R ^a   Shurin, Galina V ^a   Chatta, Gurkamal S ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Aging; Cancer; Dendritic cells; Immunosenescence; Immunosuppression

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR VACCINE;

AGING; ANTIGEN PRESENTATION; AUTOIMMUNITY; B LYMPHOCYTE; CELL COUNT; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; DENDRITIC CELL; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSENSOR; IMMUNOSURVEILLANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOCYTE; NONHUMAN; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

AGING; ANIMALS; CELL COUNT; DENDRITIC CELLS; HUMANS; IMMUNE SYSTEM; NEOPLASMS;

EID: 34250367764     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2007.03.002     Document Type: Review

References (104)

1. Pawelec G., and Solana R. Immunosenescence. Immunol Today 18 (1997) 514-516
2. Wick G., and Grubeck-Loebenstein B. Immunity and aging. Dev Comp Immunol 21 (1997) 455-460
3. Castle S.C. Clinical relevance of age-related immune dysfunction. Clin Infect Dis 31 (2000) 578-585
4. Globerson A., and Effros R.B. Ageing of lymphocytes and lymphocytes in the aged. Immunol Today 21 (2000) 515-521
5. Pawelec G., Akbar A., Caruso C., Effros R., Grubeck-Loebenstein B., and Wikby A. Is immunosenescence infectious?. Trends Immunol 25 (2004) 406-410
6. Plackett T.P., Boehmer E.D., Faunce D.E., and Kovacs E.J. Aging and innate immune cells. J Leukoc Biol 76 (2004) 291-299
7. Shortman K. Burnet oration: dendritic cells-multiple subtypes, multiple origins, multiple functions. Immunol Cell Biol 78 (2000) 161-165
8. Kronin V., Fitzmaurice C.J., Caminschi I., Shortman K., Jackson D.C., and Brown L.E. Differential effect of CD8(+) and CD8(-) dendritic cells in the stimulation of secondary CD4(+) T cells. Int Immunol 13 (2001) 465-473
9. Granucci F., Foti M., and Ricciardi-Castagnoli P. Dendritic cell biology. Adv Immunol 88 (2005) 193-233
10. Aydar Y., Balogh P., Tew J.G., and Szakal A.K. Follicular dendritic cells in aging, a "bottle-neck" in the humoral immune response. Ageing Res Rev 3 (2004) 15-29
11. Uyemura K., Castle S.C., and Makinodan T. The frail elderly: role of dendritic cells in the susceptibility of infection. Mech Ageing Dev 123 (2002) 955-962
12. Saurwein-Teissl M., Romani N., and Grubeck-Loebenstein B. Dendritic cells in old age-neglected by gerontology?. Mech Ageing Dev 121 (2000) 123-130
13. Franceschi C., Monti D., Sansoni P., and Cossarizza A. The immunology of exceptional individuals: the lesson of centenarians. Immunol Today 16 (1995) 12-16
14. Shurin M.R., and Gabrilovich D.I. Regulation of dendritic cell system by tumor. Cancer Res Ther Control 11 (2001) 65-78
15. Nestle F.O., Banchereau J., and Hart D. Dendritic cells: on the move from bench to bedside. Nat Med 7 (2001) 761-765
16. Hart D.N. Dendritic cells and their emerging clinical applications. Pathology 33 (2001) 479-492
17. Lipscomb M.F., and Masten B.J. Dendritic cells: immune regulators in health and disease. Physiol Rev 82 (2002) 97-130
18. Schwartz J.L., Weichselbaum R., and Frim S.R. The effect of aging on the density and distribution of oral mucosal Langerhans cells. Exp Gerontol 18 (1983) 65-71
19. Sprecher E., Becker Y., Kraal G., Hall E., Harrison D., and Shultz L.D. Effect of aging on epidermal dendritic cell populations in C57BL/6J mice. J Invest Dermatol 94 (1990) 247-253
20. Belsito D.V., Epstein S.P., Schultz J.M., Baer R.L., and Thorbecke G.J. Enhancement by various cytokines or 2-beta-mercaptoethanol of Ia antigen expression on Langerhans cells in skin from normal aged and young mice. Effect of cyclosporine A. J Immunol 143 (1989) 1530-1536
21. Choi K.L., and Sauder D.N. Epidermal Langerhans cell density and contact sensitivity in young and aged BALB/c mice. Mech Ageing Dev 39 (1987) 69-79
22. Cumberbatch M., Dearman R.J., and Kimber I. Influence of ageing on Langerhans cell migration in mice: identification of a putative deficiency of epidermal interleukin-1beta. Immunology 105 (2002) 466-477
23. Hazlett L.D., Moon M.M., Dawisha S., and Berk R.S. Age alters ADPase positive dendritic (Langerhans) cell response to P. aeruginosa ocular challenge. Curr Eye Res 5 (1986) 343-355
24. Rittman B.R., Hill M.W., Rittman G.A., and Mackenzie I.C. Age-associated changes in Langerhans cells of murine oral epithelium and epidermis. Arch Oral Biol 32 (1987) 885-889
25. Saint-Andre Marchal I., Dezutter-Dambuyant C., Martin J.P., et al. Quantitative assessment of feline epidermal Langerhans cells. Br J Dermatol 136 (1997) 961-965
26. Sunderkotter C., Kalden H., and Luger T.A. Aging and the skin immune system. Arch Dermatol 133 (1997) 1256-1262
27. Tourkova I.L., Yamabe K., Foster B., et al. Murine prostate cancer inhibits both in vivo and in vitro generation of dendritic cells from bone marrow precursors. Prostate 59 (2004) 203-213
28. Nabarra B., and Andrianarison I. Ultrastructural study of thymic microenvironment involution in aging mice. Exp Gerontol 31 (1996) 489-506
29. Ishikawa S., Sato T., Abe M., et al. Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J Exp Med 193 (2001) 1393-1402
30. Ishikawa S., Nagai S., Sato T., et al. Increased circulating CD11b+CD11c+ dendritic cells (DC) in aged BWF1 mice which can be matured by TNF-alpha into BLC/CXCL13-producing DC. Eur J Immunol 32 (2002) 1881-1887
31. Kabel P.J., Voorbij H.A., van der Gaag R.D., Wiersinga W.M., de Haan M., and Drexhage H.A. Dendritic cells in autoimmune thyroid disease. Acta Endocrinol Suppl 281 (1987) 42-48
32. Garg M., Luo W., Kaplan A.M., and Bondada S. Cellular basis of decreased immune responses to pneumococcal vaccines in aged mice. Infect Immun 64 (1996) 4456-4462
33. Kumagai T., Morimoto K., Saitoh T., Tsuboi I., Aikawa S., and Horie T. Age-related changes in myelopoietic response to lipopolysaccharide in senescence-accelerated (SAM) mice. Mech Ageing Dev 112 (2000) 153-167
34. Chatta G.S., Andrews R.G., Rodger E., Schrag M., Hammond W.P., and Dale D.C. Hematopoietic progenitors and aging: alterations in granulocytic precursors and responsiveness to recombinant human G-CSF, GM-CSF, and IL-3. J Gerontol 48 (1993) M207-M212
35. Globerson A. Hematopoietic stem cells and aging. Exp Gerontol 34 (1999) 137-146
36. Pinto A., De Filippi R., Frigeri F., Corazzelli G., and Normanno N. Aging and the hemopoietic system. Crit Rev Oncol Hematol 48 (2003) S3-S12
37. Maraskovsky E., Brasel K., Teepe M., et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med 184 (1996) 1953-1962
38. Shurin M.R., Pandharipande P.P., Zorina T.D., et al. FLT3 ligand induces the generation of functionally active dendritic cells in mice. Cell Immunol 179 (1997) 174-184
39. Shurin G.V., Chatta G.S., Tourkova I.L., Zorina T.D., Esche C., and Shurin M.R. Regulation of dendritic cell expansion in aged athymic nude mice by FLT3 ligand. Exp Gerontol 39 (2004) 339-348
40. Tourkova I.L., Yurkovetsky Z.R., Shurin M.R., and Shurin G.V. Mechanisms of dendritic cell-induced T cell proliferation in the primary MLR assay. Immunol Lett 78 (2001) 75-82
41. Haruna H., Inaba M., Inaba K., et al. Abnormalities of B cells and dendritic cells in SAMP1 mice. Eur J Immunol 25 (1995) 1319-1325
42. Komatsubara S., Cinader B., and Muramatsu S. Polymorphism of age-related changes in stimulatory capacity of murine dendritic cells. Mech Ageing Dev 37 (1986) 163-173
43. Komatsubara S., Cinader B., and Muramatsu S. Functional competence of dendritic cells of ageing C57BL/6 mice. Scand J Immunol 24 (1986) 517-525
44. Gu S.Q., Sakuma M., Naito S., Baba T., and Uyeno K. Surface densities of murine Ia+ dendritic epidermal cells (Ia+DECs) and Thy-1+ dendritic epidermal cells (Thy-1+DECs) in relationship to aging and ultraviolet B (UVB) radiation. J Dermatol 13 (1986) 433-439
45. Gu S.Q., Sakuma M., Naito S., Baba T., and Uyeno K. The murine (C3H/He) epidermal Ia+ dendritic cells (Ia+DECs) and Thy-1+ dendritic cells (Thy-1+DECs) in contact hypersensitivity and aging. Acta Derm Venereol 69 (1989) 1-5
46. Grewe M. Chronological ageing and photoageing of dendritic cells. Clin Exp Dermatol 26 (2001) 608-612
47. Plowden J., Renshaw-Hoelscher M., Gangappa S., Engleman C., Katz J.M., and Sambhara S. Impaired antigen-induced CD8+ T cell clonal expansion in aging is due to defects in antigen presenting cell function. Cell Immunol 229 (2004) 86-92
48. Donnini A., Argentati K., Mancini R., et al. Phenotype, antigen-presenting capacity, and migration of antigen-presenting cells in young and old age. Exp Gerontol 37 (2002) 1097-1112
49. Grolleau-Julius A., Garg M.R., Mo R., Stoolman L.L., and Yung R.L. Effect of aging on bone marrow-derived murine CD11c+CD4-CD8alpha-dendritic cell function. J Gerontol A Biol Sci Med Sci 61 (2006) 1039-1047
50. Kato H., Fujihashi K., Kato R., et al. Lack of oral tolerance in aging is due to sequential loss of Peyer's patch cell interactions. Int Immunol 15 (2003) 145-158
51. Manning B.M., Enioutina E.Y., Visic D.M., Knudson A.D., and Daynes R.A. CpG DNA functions as an effective adjuvant for the induction of immune responses in aged mice. Exp Gerontol 37 (2001) 107-126
52. Gilchrest B.A., Murphy G.F., and Soter N.A. Effect of chronologic aging and ultraviolet irradiation on Langerhans cells in human epidermis. J Invest Dermatol 79 (1982) 85-88
53. Thiers B.H., Maize J.C., Spicer S.S., and Cantor A.B. The effect of aging and chronic sun exposure on human Langerhans cell populations. J Invest Dermatol 82 (1984) 223-226
54. Ghersetich I., and Lotti T. alpha-Interferon cream restores decreased levels of Langerhans/indeterminate (CD1a+) cells in aged and PUVA-treated skin. Skin Pharmacol 7 (1994) 118-120
55. Bhushan M., Cumberbatch M., Dearman R.J., Andrew S.M., Kimber I., and Griffiths C.E. Tumour necrosis factor-alpha-induced migration of human Langerhans cells: the influence of ageing. Br J Dermatol 146 (2002) 32-40
56. Bhushan M., Cumberbatch M., Dearman R.J., Kimber I., and Griffiths C.E. Exogenous interleukin-1beta restores impaired Langerhans cell migration in aged skin. Br J Dermatol 150 (2004) 1217-1218
57. Wulf H.C., Sandby-Moller J., Kobayasi T., and Gniadecki R. Skin aging and natural photoprotection. Micron 35 (2004) 185-191
58. Indrasingh I., Chandi G., Jeyaseelan L., Vettivel S., and Chandi S.M. Quantitative analysis of CD1a (T6) positive Langerhans cells in human tonsil epithelium. Anat Anz 181 (1999) 567-572
59. Zavala W.D., and Cavicchia J.C. Deterioration of the Langerhans cell network of the human gingival epithelium with aging. Arch Oral Biol 51 (2006) 1150-1155
60. Nakahama M., Mohri N., Mori S., Shindo G., Yokoi Y., and Machinami R. Immunohistochemical and histometrical studies of the human thymus with special emphasis on age-related changes in medullary epithelial and dendritic cells. Virchows Arch B Cell Pathol Incl Mol Pathol 58 (1990) 245-251
61. Varas A., Sacedon R., Hernandez-Lopez C., et al. Age-dependent changes in thymic macrophages and dendritic cells. Microsc Res Tech 62 (2003) 501-507
62. Teig N., Moses D., Gieseler S., and Schauer U. Age-related changes in human blood dendritic cell subpopulations. Scand J Immunol 55 (2002) 453-457
63. Shodell M., and Siegal F.P. Circulating, interferon-producing plasmacytoid dendritic cells decline during human ageing. Scand J Immunol 56 (2002) 518-521
64. Della Bella S., Bierti L., Presicce P., et al. Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin Immunol (2006)
65. Steger M.M., Maczek C., and Grubeck-Loebenstein B. Morphologically and functionally intact dendritic cells can be derived from the peripheral blood of aged individuals. Clin Exp Immunol 105 (1996) 544-550
66. Steger M.M., Maczek C., and Grubeck-Loebenstein B. Peripheral blood dendritic cells reinduce proliferation in in vitro aged T cell populations. Mech Ageing Dev 93 (1997) 125-130
67. Lung T.L., Saurwein-Teissl M., Parson W., Schonitzer D., and Grubeck-Loebenstein B. Unimpaired dendritic cells can be derived from monocytes in old age and can mobilize residual function in senescent T cells. Vaccine 18 (2000) 1606-1612
68. Xu X., Beckman I., Dimopoulos K., Ahern M., and Bradley J. Age-related changes in the expression of T cell activation antigens following phytohaemagglutinin stimulation. Exp Clin Immunogenet 9 (1992) 203-211
69. Beckman I., Dimopoulos K., Xu X.N., Bradley J., Henschke P., and Ahern M. T cell activation in the elderly: evidence for specific deficiencies in T cell/accessory cell interactions. Mech Ageing Dev 51 (1990) 265-276
70. Saurwein-Teissl M., Schonitzer D., and Grubeck-Loebenstein B. Dendritic cell responsiveness to stimulation with influenza vaccine is unimpaired in old age. Exp Gerontol 33 (1998) 625-631
71. Pietschmann P., Hahn P., Kudlacek S., Thomas R., and Peterlik M. Surface markers and transendothelial migration of dendritic cells from elderly subjects. Exp Gerontol 35 (2000) 213-224
72. Wick G., and Grubeck-Loebenstein B. The aging immune system: primary and secondary alterations of immune reactivity in the elderly. Exp Gerontol 32 (1997) 401-413
73. Bagnara G.P., Bonsi L., Strippoli P., et al. Hemopoiesis in healthy old people and centenarians: well-maintained responsiveness of CD34+ cells to hemopoietic growth factors and remodeling of cytokine network. J Gerontol A Biol Sci Med Sci 55 (2000) B61-B66
74. Castle S.C., Uyemura K., Crawford W., Wong W., and Makinodan T. Antigen presenting cell function is enhanced in healthy elderly. Mech Ageing Dev 107 (1999) 137-145
75. Castle S.C., Uyemura K., Crawford W., Wong W., Klaustermeyer W.B., and Makinodan T. Age-related impaired proliferation of peripheral blood mononuclear cells is associated with an increase in both IL-10 and IL-12. Exp Gerontol 34 (1999) 243-252
76. Looney R.J., Falsey A.R., Walsh E., and Campbell D. Effect of aging on cytokine production in response to respiratory syncytial virus infection. J Infect Dis 185 (2002) 682-685
77. Balducci L., Hardy C.L., and Lyman G.H. Hematopoietic growth factors in the older cancer patient. Curr Opin Hematol 8 (2001) 170-187
78. Young M.R., Kolesiak K., Achille N.J., et al. Impact of aging on immune modulation by tumor. Cancer Immunol Immunother 50 (2001) 315-320
79. Baraldi-Junkins C.A., Beck A.C., and Rothstein G. Hematopoiesis and cytokines. Relevance to cancer and aging. Hematol Oncol Clin North Am 14 (2000) 45-61
80. Lipschitz D.A. Age-related declines in hematopoietic reserve capacity. Semin Oncol 22 (1995) 3-5
81. Shurin M.R., Lu L., Kalinski P., Stewart-Akers A.M., and Lotze M.T. Th1/Th2 balance in cancer, transplantation and pregnancy. Springer Semin Immunopathol 21 (1999) 339-359
82. Lappin M.B., and Campbell J.D. The Th1-Th2 classification of cellular immune responses: concepts, current thinking and applications in haematological malignancy. Blood Rev 14 (2000) 228-239
83. Candore G., Di Lorenzo G., Melluso M., et al. gamma-Interferon, interleukin-4 and interleukin-6 in vitro production in old subjects. Autoimmunity 16 (1993) 275-280
84. Gabrilovich D.I., Chen H.L., Girgis K.R., Cunningham H.T., Meny G.M., Nadaf S., Kavanaugh D., and Carbone D.P. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2 (1996) 1096-1103
85. Caux C., Massacrier C., Dubois B., et al. Respective involvement of TGF-beta and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors. J Leukoc Biol 66 (1999) 781-791
86. Shurin M.R., Yurkovetsky Z.R., Tourkova I.L., Balkir L., and Shurin G.V. Inhibition of CD40 expression and CD40-mediated dendritic cell function by tumor-derived IL-10. Int J Cancer 101 (2002) 61-68
87. Shurin M.R., Shurin G.V., Lokshin A., et al. Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies?. Cancer Metastasis Rev 25 (2006) 333-356
88. Plett P.A., Gardner E.M., and Murasko D.M. Age-related changes in interferon-alpha/beta receptor expression, binding, and induction of apoptosis in natural killer cells from C57BL/6 mice. Mech Ageing Dev 118 (2000) 129-144
89. Rink L., Cakman I., and Kirchner H. Altered cytokine production in the elderly. Mech Ageing Dev 102 (1998) 199-209
90. Sandmand M., Bruunsgaard H., Kemp K., et al. Is ageing associated with a shift in the balance between Type 1 and Type 2 cytokines in humans?. Clin Exp Immunol 127 (2002) 107-114
91. Provinciali M., Smorlesi A., Donnini A., Bartozzi B., and Amici A. Low effectiveness of DNA vaccination against HER-2/neu in ageing. Vaccine 21 (2003) 843-848
92. Shi M., Bi X., Xu S., He Y., Guo X., and Xiang J. Increased susceptibility of tumorigenicity and decreased anti-tumor effect of DC vaccination in aged mice are potentially associated with increased number of NK1.1+CD3+ NKT cells. Exp Oncol 27 (2005) 125-129
93. Sharma S., Dominguez A.L., and Lustgarten J. Aging affect the anti-tumor potential of dendritic cell vaccination, but it can be overcome by co-stimulation with anti-OX40 or anti-4-1BB. Exp Gerontol 41 (2006) 78-84
94. Yurkovetsky Z.R., Shurin G.V., Barry D.A., Schuh A.C., Shurin M.R., and Robbins P.D. Comparative analysis of antitumor activity of CD40L, RANKL, and 4-1BBL in vivo following intratumoral administration of viral vectors or transduced dendritic cells. J Gene Med 8 (2006) 129-137
95. Freyer G., Maire P., Ardiet C., Tranchand B., and Droz J.P. Cytotoxic chemotherapy in elderly patients: present and future. Bull Cancer 82 (1995) 531-540
96. Hosono M., Inaba K., Yano K., Katsura Y., and Muramatsu S. Autostimulatory adherent cells in the spleen of aging mice: characterization in the syngeneic host-versus-graft reaction. Mech Ageing Dev 28 (1984) 67-81
97. Villadsen J.H., Langkjer S.T., Ebbesen P., and Bjerring P. Syngrafting skin among mice of similar and different ages increases the number of Langerhans cells and decreases responsiveness to 1,4-dinitrofluorobenzene. Comp Gerontol [A] 1 (1987) 78-79
98. Linton P.J., Li S.P., Zhang Y., Bautista B., Huynh Q., and Trinh T. Intrinsic versus environmental influences on T-cell responses in aging. Immunol Rev 205 (2005) 207-219
99. Tesar B.M., Walker W.E., Unternaehrer J., et al. Nurine myeloid dendritic cell-dependent toll-like receptor immunity is preserved with aging. Aging Cell 5 (2006) 473-486
100. Gilhar A., Pillar T., David M., and Eidelman S. Melanocytes and Langerhans cells in aged versus young skin before and after transplantation onto nude mice. J Invest Dermatol 96 (1991) 210-214
101. Sasaki M. Histomorphometric analysis of age-related changes in epithelial thickness and Langerhans cell density of the human tongue. Tohoku J Exp Med 173 (1994) 321-336
102. Cruchley A.T., Williams D.M., Farthing P.M., Speight P.M., Lesch C.A., and Squier C.A. Langerhans cell density in normal human oral mucosa and skin: relationship to age, smoking and alcohol consumption. J Oral Pathol Med 23 (1994) 55-59
103. Steuhl K.P., Sitz U., Knorr M., Thanos S., and Thiel H.J. Age-dependent distribution of Langerhans cells within human conjunctival epithelium. Ophthalmologe 92 (1995) 21-25
104. Gomez I., Marx F., Gould E.A., and Grubeck-Loebenstein B. T cells from elderly persons respond to neoantigenic stimulation with an unimpaired IL-2 production and an enhanced differentiation into effector cells. Exp Gerontol 39 (2004) 597-605